
Trained on data from NASA’s exoplanet-hunting missions, the open-source ExoMiner++ deep learning model uses an advanced algorithm to validate new planets.
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.